Although both HPV16+ and HPV18+ cervical cancer cell lines responded to IMD 0354, however, IMD 0354-mediated inhibition of IKKβ exhibited greater effectiveness on HeLa cells (HPV 18+) compared with SiHa and CaSki cells (HPV 16+). Here, IKBKB is linked to cervical carcinoma.